+128.9%
IBM vs EMR
+266.6%
-137.6%
-40.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.7% | -0.9% | -3.8% | -4.3% |
| 7D | -5.5% | -4.7% | -0.8% | -3.7% |
| 30D | +0.2% | -1.1% | +1.3% | +0.6% |
| 3M | +1.7% | -1.4% | +3.1% | +1.9% |
| 6M | +6.9% | +20.5% | -13.6% | -1.9% |
| YTD | -19.8% | +21.7% | -41.5% | -27.5% |
| 1Y | -20.1% | +27.3% | -47.4% | -29.2% |
| 3Y | +65.1% | +87.5% | -22.4% | +19.5% |
| 5Y | +135.5% | +86.0% | +49.5% | +67.3% |
| 10Y | +128.9% | +269.2% | -140.3% | +20.3% |
| All | +128.9% | +266.6% | -137.6% | +20.3% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling